Deep Track Capital, LP - Significant Ownership

Signature - Title: Nir Messafi - CCO/COO/CFO
Location: Greenwich, CT
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Deep Track Capital, LP.

Significant Ownership of Deep Track Capital, LP

Sym	Company	Class	Ownership	Holdings Value	Nb Shares	Reporting Name	Report Period
DVAX	Dynavax Technologies Corporation	Common Stock, par value $0.001 per share	13.5%	$239M	17.8M	Deep Track Biotechnology Master Fund, Ltd.	Feb 18, 2025
CMPS	COMPASS Pathways plc	American Depositary Shares, each representing one ordinary share, par value of (pound)0.008 per share	9.99%	$34.6M	9.27M	Deep Track Capital, LP	Jan 10, 2025
RAPT	RAPT Therapeutics, Inc.	Common Stock $0.0001 par value per share	9.87%	$17.6M	14.1M	Deep Track Capital, LP	Dec 23, 2024
ENGN	enGene Holdings Inc.	Common Shares	8.94%	$24.1M	4.56M	Deep Track Capital, LP	Dec 31, 2024
TECX	Tectonic Therapeutic Inc.	Common Stock $0.001 par value per share	7.6%	$34.5M	1.4M	Deep Track Capital, LP	Feb 3, 2025
DNTH	Dianthus Therapeutics Inc.	Common Stock, $0.001 Par Value	7.34%	$50.2M	2.36M	Deep Track Capital, LP	Mar 17, 2025
MAZE	Maze Therapeutics Inc.	Common Stock, $0.001 par value per share	6.91%	$34.2M	3.02M	Deep Track Capital, LP	Jan 31, 2025
BCYC	Bicycle Therapeutics plc	American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share	6.71%	$34.6M	3.33M	Deep Track Capital, LP	Dec 31, 2024
IMVT	Immunovant Inc.	Common Stock, $0.0001 par value per share	5.59%	$193M	9.5M	Deep Track Capital, LP	Mar 19, 2025
GERN	Geron Corp	Common Stock, $0.001 par value	5.5%	$56M	35M	Deep Track Capital, LP	Mar 18, 2025
NRIX	Nurix Therapeutics, Inc.	Common Stock, par value $0.001 per share	5.44%	$54.4M	4.13M	Deep Track Capital, LP	Feb 7, 2025
ETNB	89bio, Inc.	Common stock, par value $0.001 per share	5.41%	$46.3M	6.48M	Deep Track Capital, LP	Dec 19, 2024
GPCR	Structure Therapeutics Inc.	Ordinary Shares, $0.0001 par value	5.24%	$193M	9M	Deep Track Capital, LP	Jan 6, 2025
IKNA	Ikena Oncology, Inc.	Common Stock, $0.001 par value	5.21%	$4.2M	2.52M	Deep Track Capital, LP	Feb 7, 2025
SWTX	Springworks Therapeutics, Inc.	Common Stock, par value $0.0001 per share	4.65%	$172M	3.46M	Deep Track Capital, LP	Dec 31, 2024
OKUR	Onkure Therapeutics, Inc.	Common Stock, par value $0.0001 per share	4.14%	$2.59M	524K	Deep Track Capital, LP	Dec 31, 2024
FDMT	4D Molecular Therapeutics Inc.	Common Stock, par value $0.0001 per share	1.32%	$2.52M	610K	Deep Track Capital, LP	Dec 31, 2024
NKTR	Nektar Therapeutics	Common Stock, par value $0.0001	1.07%	$1.62M	1.98M	Deep Track Capital, LP	Dec 31, 2024
PYXS	Pyxis Oncology, Inc.	Common Stock, par value $0.001 per share	0%	$0	0	Deep Track Capital, LP	Dec 31, 2024
EDIT	Editas Medicine, Inc.	Common Stock, $0.0001 par value per share	0%	$0	0	Deep Track Capital, LP	Dec 31, 2024
SYRS	Syros Pharmaceuticals, Inc.	Common Stock, $0.001 par value	0%	$0	0	Deep Track Capital, LP	Dec 31, 2024

Previous1Next

Showing 1 to 21 of 21 entries

Schedules 13D/G Reported by Deep Track Capital, LP:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Date Filed
Loading...

PreviousNext

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.